The immune paradox of sarcoidosis and regulatory T cells
Makoto Miyara(Kyoto University), Guy Gorochov(Inserm), Karim Dorgham(Inserm), Zahir Amoura(Sorbonne Université), S. Trad(Inserm), Marianne Kambouchner(Hôpital Avicenne), Dominique Valeyre(Inserm), C. Chapelon-Abric(Sorbonne Université), Jean‐Charles Piette(Sorbonne Université), Christophe Parizot(Inserm), Patrice Debré(Centre National de la Recherche Scientifique), Cécile Badoual(Inserm)
Cited by 444
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
|Immunity|2009|2.3k
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
|The Lancet|2011|2.1k
Sarcoidosis
|The Lancet|2013|1.1k
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
|European Respiratory Journal|2005|1k